Windlas Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

630.96

513.08

465.93

427.60

328.85

Operating profit

78.10

60.24

52.90

54.69

40.67

Interest

1.10

0.79

1.42

1.29

2.37

Gross profit

90.47

69.42

58.18

56.50

39.26

EPS (Rs)

27.96

20.38

17.69

3.91

17.52

Other income

13.47

9.97

6.71

3.09

0.96

Stock adjustment

9.59

-15.27

-4.74

3.67

-12.75

Raw material

386.59

340.71

307.56

270.74

224.35

Power and fuel

-

-

-

-

-

Employee expenses

87.46

70.32

63.41

58.32

43.88

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

69.22

57.07

46.81

40.18

32.70

Provisions made

-

-

-

-

-

Depreciation

13.44

12.36

12.15

12.97

8.69

Taxation

18.88

14.41

7.48

6.17

8.12

Net profit / loss

58.14

42.64

38.56

5.01

22.46

Extra ordinary item

-

-

-

-32.35

-

Prior year adjustments

-

-

-

-

-

Equity capital

10.40

10.46

10.90

6.41

6.41

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.38

11.74

11.35

12.79

12.37

GPM (%)

14.04

13.27

12.31

13.12

11.90

NPM (%)

9.02

8.15

8.16

1.16

6.81